Team
Portfolio
News
Contact

Back to Portfolio

Alumis

Website LinkedIn

Clinical stage company developing next generation TYK2 inhibitors for autoimmune diseases

Therapeutic Area
Immunology: Stage
Clinical: CEO
Martin Babler: Geography
South San Francisco, CA

© 2024 SR One Capital ManagementLinkedIn

For media enquires, please email sronemedia@sambrown.com

California

929 Main Street
Suite 200
Redwood City, CA 94063
United States

Pennsylvania

985 Old Eagle School Road
Suite 511
Wayne, PA 19087
United States

London

29 Farm Street
London
W1J 5RL
United Kingdom

Privacy Policy Terms & Conditions Regulatory Disclosures